Entrada Therapeutics
Yuwei (Cindy) Wang, PhD has a diverse and extensive work experience. Yuwei (Cindy) is currently working at Entrada Therapeutics as a Senior Scientist I since June 2023. Prior to that, they worked at EyePoint Pharmaceuticals as a Senior Scientist from February 2022 to May 2023. Yuwei (Cindy) also worked at CuriRx, Inc as a Formulation Scientist from May 2021 to February 2022.
Before their industry roles, Cindy held positions at prestigious academic institutions. Yuwei (Cindy) served as a Lab Manager/Postdoctoral Research Associate at Boston College and Princeton University from November 2019 to April 2021. During this time, they conducted research on the transformation of mercury by anaerobic bacteria and collaborated on proteomics data analysis. Additionally, they performed experiments on mineral generation and interacted with undergraduate research assistants.
Prior to their postdoctoral positions, Cindy worked at Rutgers University–New Brunswick. Here, they held multiple roles including Research Associate, Research Assistant, and Teaching Assistant. As a Research Associate from October 2019 to November 2019, Cindy conducted independent dissertation research on the transformation of mercury by anaerobic bacteria. Yuwei (Cindy) also mentored undergraduate research assistants, collaborated on determining bacterial surface thiol sites, and performed experiments on mineral generation and interaction.
Cindy's career in research started at South China University of Technology, where they served as an Undergraduate Research Assistant from September 2012 to May 2014. Yuwei (Cindy) then had internships at The Science and Technology Center of Baogang Group, where they worked on air and water quality testing, and at BERIS Engineering and Research Corporation, where they assisted in drafting engineering drawings and writing environmental impact reports.
Overall, Cindy Wang, PhD has a well-rounded and extensive background in scientific research and industry work.
Dr. Yuwei (Cindy) Wang holds a Doctor of Philosophy (PhD) degree in Environmental Science (Biogeochemistry) from Rutgers University–New Brunswick. Yuwei (Cindy) pursued their doctoral studies from 2014 to 2019. Prior to their PhD, Dr. Wang completed their Bachelor of Science (B.S.) in Environmental Science at South China University of Technology, where they studied from 2010 to 2014.
Entrada Therapeutics
2 followers
Entrada Therapeutics’ mission is to transform the treatment of devastating diseases and improve patients' quality of life by developing intracellular biologics.